Shopping Cart
Remove All
Your shopping cart is currently empty
BGB-8035 is an orally available, selective and potent BTK inhibitor with antitumor activity that inhibits BTK, TEC and EGFR.BGB-8035 is used in the study of tumors and autoimmune diseases.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $81 | In Stock | In Stock | |
| 5 mg | $163 | In Stock | In Stock | |
| 10 mg | $243 | - | In Stock | |
| 25 mg | $397 | - | In Stock | |
| 50 mg | $598 | - | In Stock |
| Description | BGB-8035 is an orally available, selective and potent BTK inhibitor with antitumor activity that inhibits BTK, TEC and EGFR.BGB-8035 is used in the study of tumors and autoimmune diseases. |
| Targets&IC50 | EGFR:621 nM, TEC:99 nM, BTK:1.1 nM |
| In vivo | In 9-week-old female NOD/SCID mice harboring REC-1 MCL xenografts, BGB-8035 (administered at doses of 7.5, 15, and 30 mg/kg; oral dosing; twice daily) exhibited dose-dependent antitumor activity, with corresponding Tumor Growth Inhibition (TGI) values of 64.1%, 73.6%, and 79.9%, respectively[1]. |
| Synonyms | BGB8035, BGB 8035 |
| Molecular Weight | 453.53 |
| Formula | C24H31N5O4 |
| Cas No. | 2283349-24-4 |
| Smiles | C(N)(=O)C1=C2N([C@@H](CCN2)C3CCN(C(C=C)=O)CC3)N=C1C4=CC(OC)=C(C)C(OC)=C4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.